Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 10/5/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 10/5/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| -3.10% | -4.19% | +32.67% | +59.47% | 63.48B | |
| +1.53% | +1.04% | +11.57% | +81.71% | 54.55B | |
| -0.87% | +1.54% | +11.05% | +103.27% | 53.59B | |
| -0.75% | +1.38% | +24.89% | +50.91% | 44.75B | |
| -1.30% | -4.80% | +16.05% | +114.76% | 41.62B | |
| +1.26% | -5.26% | +221.12% | +900.64% | 39.91B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.47B | |
| +0.07% | +14.66% | +60.86% | +50.88% | 26.7B | |
| +3.72% | -6.07% | +26.22% | -8.12% | 23.36B | |
| Average | -0.00% | -1.19% | +46.16% | +155.35% | 42.27B | |
| Weighted average by Cap. | -0.34% | -1.27% | +43.37% | +156.11% |
Employees
457
